Reversing the negative effect of adenosine A1 receptor-targeted immunometabolism modulation on melanoma by a co-delivery nanomedicine for self-activation of anti-PD-L1 DNAzyme

• DOI: 10.1016/j.nantod.2022.101722
• Publication Date: 2022-12-16T17:52:35Z
• Authors: Jia Guo; Peng Liu; Benliang Wei; Ying Peng; Jinsong Ding; Hailun Zhang; Guanxiong Zhang; Juan Su; Hong Liu; Wenhu Zhou; Xiang Chen
• Keywords: Cancer Immunotherapy